Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Eli Lilly: Diabetes & Obesity president to retire; shares dip

EditorPollock Mondal
Published 10/04/2023, 07:12 AM
©  Reuters Eli Lilly (LLY): Diabetes & Obesity President to retire; shares dip

Eli Lilly and Company (NYSE:LLY) announced today that Mike Mason, who has served as executive vice president (EVP) and president of Lilly Diabetes and Obesity for 34 years, will retire at the end of 2023.

Shares fell 1% on the announcement.

Patrik Jonsson will take over leadership of Lilly Diabetes and Obesity while continuing his role as EVP and president of Lilly USA.

"As we embark on this exciting new chapter of growth for our company, I've never been more confident about our ability to deliver life-changing medicines to the patients who need them," said David A. Ricks, Lilly's chair and CEO. "The deep experience of our leadership team ensures that we will continue to accelerate our efforts in effective, innovative ways."

Moreover, Daniel Skovronsky, the company's chief scientific officer and president of Lilly Research Laboratories, will assume the additional position of president of Lilly Immunology, taking over from Jonsson.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.